← Back to Trial

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

Trial Locations

  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
    • Contact: National Cancer Institute Referral Office Ā· 888-624-1937